These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7794292)

  • 1. Divergent neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca2+ homeostasis in dementia.
    Fischhof PK
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):549-55. PubMed ID: 7794292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine selectively stimulates beta-amyloid 1-42 secretion by a mechanism independent of calcium influx blockage.
    Facchinetti F; Fasolato C; Del Giudice E; Burgo A; Furegato S; Fusco M; Basso E; Seraglia R; D'Arrigo A; Leon A
    Neurobiol Aging; 2006 Feb; 27(2):218-27. PubMed ID: 16399208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brain aging and calcium antagonist drugs. A preliminary open study with nimodipine].
    Centonze V; Massaro C; Polito BM; Cassiano MA; Di Bari M; Russo P; Cirillo L; Albano O
    Clin Ter; 1992 Jan; 140(1):11-5. PubMed ID: 1526092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia.
    Dysken MW; Katz R; Stallone F; Kuskowski M
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):249-52. PubMed ID: 2521069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological basis for the use of nimodipine in central nervous system disorders.
    Scriabine A; Schuurman T; Traber J
    FASEB J; 1989 May; 3(7):1799-806. PubMed ID: 2565839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigations with ateroid in old-age dementias.
    Ban TA; Morey LC; Santini V
    Semin Thromb Hemost; 1991; 17 Suppl 2():161-3. PubMed ID: 1719637
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells.
    Zhu D; Li R; Liu G; Hua W
    Life Sci; 1999; 65(15):PL221-31. PubMed ID: 10574230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
    Zhang JT
    Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.